Home » Vertex Shares Soar on Cystic Fibrosis Drug Data
Vertex Shares Soar on Cystic Fibrosis Drug Data
An experimental drug made by Vertex Pharmaceuticals Inc. significantly improved lung function in patients with cystic fibrosis, sending the company’s shares up 18 percent to a four-year high.
CNBC
CNBC
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May